Figure 7
From: Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
Effects of sorafenib on c-met protein expression levels. (A) c-met copy number analysis in the 4 HCC cell lines considered and comparison with the highest percentage of inhibition of proliferation observed after sorafenib treatments. (B) Western blot and densitometric analysis of c-met, p-c-met (Y1003) and GAPDH in the HA22T/VGH and HepG2 cells treated with sorafenib *p < 0.05; **p < 0.01 versus HA22T/VGH or HepG2 in a t-Test analysis for unpaired comparison.